[Inhibition of leukocyte migration in tuberculosis and diseases with cutaneous energy].
D000917:Antibody Formation; D002464:Cell Migration Inhibition; D006689:Hodgkin Disease / Q000276:immunology; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology*; D006968:Hypersensitivity, Delayed; D006969:Hypersensitivity, Immediate; D007111:Immunity, Cellular; D007945:Leukemia, Lymphoid / Q000276:immunology; D007962:Leukocytes / Q000276:immunology*; D008175:Lung Neoplasms / Q000276:immunology; D008264:Macrophages / Q000276:immunology; D008545:Melanoma / Q000276:immunology; D012507:Sarcoidosis / Q000276:immunology; D012882:Skin Tests; D014374:Tuberculin Test; D014388:Tuberculosis, Lymph Node / Q000276:immunology*; D014398:Tuberculosis, Renal / Q000276:immunology*
Inbizione della migrazione leucocitaria nella tubercolosi e in malattie con anergia cutanea